The integrated landscape of driver genomic alterations in glioblastoma.
about
Identifying fusion transcripts using next generation sequencingOncogenic kinase fusions: an evolving arena with innovative clinical opportunitiesThe Role of Hedgehog Signaling in Tumor Induced Bone DiseaseNF-κB and STAT3 in glioblastoma: therapeutic targets coming of ageMolecular characteristics of pediatric high-grade gliomasNavigating the rapids: the development of regulated next-generation sequencing-based clinical trial assays and companion diagnosticsCooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapyMouse models of cancer: Sleeping Beauty transposons for insertional mutagenesis screens and reverse genetic studiesContemporary murine models in preclinical astrocytoma drug developmentNTRK gene fusions as novel targets of cancer therapy across multiple tumour typesEpidermal growth factor signaling in transformed cellsTRKing down an old oncogene in a new era of targeted therapyAn Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101NTRK1 fusion in glioblastoma multiformeRecurrent chimeric fusion RNAs in non-cancer tissues and cells.Mitochondrial control by DRP1 in brain tumor initiating cells.Mutations in LZTR1 add to the complex heterogeneity of schwannomatosisExploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number dataAssessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial.Fluorescence in situ hybridization in surgical pathology: principles and applications.Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres.The genetic landscape of anaplastic astrocytoma.The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade gliomaA novel approach to the discovery of survival biomarkers in glioblastoma using a joint analysis of DNA methylation and gene expression.FBXW7 mutations in melanoma and a new therapeutic paradigmRole of receptor tyrosine kinases and their ligands in glioblastoma.Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target.EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties.Quantitative proteomic analysis reveals effects of epidermal growth factor receptor (EGFR) on invasion-promoting proteins secreted by glioblastoma cells.Identification of causal genetic drivers of human disease through systems-level analysis of regulatory networks.Recurrent LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes promote tumor cell motility in human osteosarcoma.Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomasThe hidden genetics of epilepsy-a clinically important new paradigm.Nuclear receptor corepressor complexes in cancer: mechanism, function and regulationDeregulated proliferation and differentiation in brain tumors.Neurotrophin signaling via TrkB and TrkC receptors promotes the growth of brain tumor-initiating cells.Sparse expression bases in cancer reveal tumor drivers.Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy.Micro-environment causes reversible changes in DNA methylation and mRNA expression profiles in patient-derived glioma stem cellsA unique four-hub protein cluster associates to glioblastoma progression.
P2860
Q26739900-66628670-A1B8-4A80-8138-B5B03ABDF319Q26768158-BCB4BCF9-5552-42A0-B85D-40BFC03FBA98Q26783615-EC97FF6B-E990-4CD4-AFA4-BC8DC9E1C2D1Q26830388-0FD8A831-008E-4A02-8CB1-8CF349209148Q26860786-B8290A4B-341F-424A-83F0-8DC55F79B0A4Q26864332-36D1B6B8-FE4F-42C4-8ADE-839BBE0351CDQ26865136-F5D46B56-9409-456E-8E32-0304FA33B3DEQ27008537-EFA750BE-885A-425D-B2BD-A4A88DE567A0Q27026937-261ED3F2-5641-40C2-B6E7-F825FFE90C3BQ28066821-44C7C781-2EF3-4969-A2D0-AFB7F3B23333Q28084034-B1763159-ACE7-4A26-9252-02E0F0E32F3FQ28254287-A6B330BC-75DA-4AEF-B0CE-53EDCE6B3A47Q28265615-5EB9E51E-6728-429F-9EEE-C1E71E006915Q28541127-EDDBE9F7-5503-4A61-8EFC-D0A26A292439Q30277623-2216729A-3C30-4BE3-8499-C9AEBA8D6BA6Q30300490-44CA4A82-C612-4C00-A546-54347E12333FQ30394068-BDA1BE8B-2667-4DAE-92B7-14D18E190FC1Q30699293-3F32565D-1757-4B1C-9B54-DD8F2B774832Q30836702-70F15069-9A08-401B-ADFE-9890B9B54D83Q33593910-4B2CC7E3-8179-470E-A9DE-913EAE7B1D85Q33643498-46950EA6-9CAB-4FFF-9E66-67E53C56EC6EQ33688888-F055C5B3-A9A2-4857-BF60-189C7B31F5BAQ33751426-220AE2B7-9C10-41F6-8F63-34A10F78006EQ33784612-CC2D2506-47DE-4CF3-818E-CD376E5D2E38Q33845217-7CC7C106-BC7A-4DCA-91B0-0B4DFDA0209CQ33883849-EB64E071-1619-4301-B32A-E262597FBF77Q33899971-F039C301-3F8C-4DAD-AA47-803DC5BA1919Q33993779-2B5D0075-783E-467B-8FEE-2D4B5484250AQ34303359-C0CB5527-787F-4988-8F4F-A61AB5B34C87Q34324288-7AC66A50-E017-44FE-BD1E-F4021860366AQ34340295-18A0A8E3-AAD1-4F16-A406-DB29E2ED5BBEQ34393793-2015F8F0-58FB-4201-93C3-5E1331344C27Q34415194-E0FD2D80-3260-4367-A873-572C87C174ECQ34448240-B1283FB1-1106-4202-96FB-216A1804C5FAQ34859989-6211A711-0837-47DC-8D29-5B6A8631229FQ35055652-2309C7F8-FC71-47F5-B7DF-FD851EC6CCD7Q35088941-405F5151-ABA5-483B-B628-EE94471D72DAQ35146078-082017B9-460A-46BC-BBD8-83E9E702C5ECQ35146816-46F7AEF9-00CC-4011-8C3C-DEE9DD5DD565Q35210961-FFD1BE5E-F973-41E9-92BD-9C6A9D2F55EF
P2860
The integrated landscape of driver genomic alterations in glioblastoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The integrated landscape of driver genomic alterations in glioblastoma.
@en
The integrated landscape of driver genomic alterations in glioblastoma.
@nl
type
label
The integrated landscape of driver genomic alterations in glioblastoma.
@en
The integrated landscape of driver genomic alterations in glioblastoma.
@nl
prefLabel
The integrated landscape of driver genomic alterations in glioblastoma.
@en
The integrated landscape of driver genomic alterations in glioblastoma.
@nl
P2093
P2860
P50
P356
P1433
P1476
The integrated landscape of driver genomic alterations in glioblastoma.
@en
P2093
Adriana Heguy
Angelica Castano
Anna Lasorella
Antonio Iavarone
Carla Danussi
David J Pisapia
Francesco Abate
Francesco Niola
Gaetano Finocchiaro
P2860
P2888
P304
P356
10.1038/NG.2734
P407
P50
P577
2013-08-05T00:00:00Z